RLN3

relaxin 3, the group of Neuropeptides

Basic information

Region (hg38): 19:14028148-14031551

Links

ENSG00000171136NCBI:117579OMIM:606855HGNC:17135Uniprot:Q8WXF3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RLN3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RLN3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
9
clinvar
2
clinvar
11
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 10 3 0

Variants in RLN3

This is a list of pathogenic ClinVar variants found in the RLN3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-14028236-C-T not specified Uncertain significance (Dec 26, 2023)3154767
19-14028266-C-T not specified Likely benign (Dec 21, 2023)3154769
19-14028292-T-C Likely benign (Feb 13, 2018)787603
19-14028325-C-T Likely benign (Jun 08, 2018)734211
19-14028370-G-C not specified Uncertain significance (Mar 11, 2022)2385154
19-14028383-A-G not specified Uncertain significance (Aug 21, 2023)2620300
19-14028385-G-A not specified Uncertain significance (Jan 10, 2022)2271598
19-14030743-A-G not specified Uncertain significance (Mar 01, 2023)2456152
19-14030755-G-A not specified Uncertain significance (Oct 06, 2021)2253447
19-14030764-A-G not specified Uncertain significance (Mar 01, 2024)3154766
19-14030806-C-A Uncertain significance (Jan 01, 2019)634528
19-14030874-G-C not specified Uncertain significance (Jan 18, 2023)2456731
19-14030881-T-C not specified Uncertain significance (Nov 28, 2023)3154768

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RLN3protein_codingprotein_codingENST00000431365 22895
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01340.6821255530831256360.000330
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1609590.71.050.00000559897
Missense in Polyphen2628.7520.90427306
Synonymous1.243040.00.7510.00000259310
Loss of Function0.56934.270.7033.67e-729

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.004190.00419
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00008810.0000880
Middle Eastern0.000.00
South Asian0.00006580.0000653
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a role in neuropeptide signaling processes. Ligand for LGR7, relaxin-3 receptor-1 (GPCR135) and relaxin-3 receptor-2 (GPCR142).;
Pathway
Relaxin signaling pathway - Homo sapiens (human);Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Relaxin receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.111

Intolerance Scores

loftool
0.548
rvis_EVS
0.57
rvis_percentile_EVS
81.99

Haploinsufficiency Scores

pHI
0.142
hipred
N
hipred_score
0.208
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.564

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rln3
Phenotype
growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;regulation of signaling receptor activity
Cellular component
extracellular region
Molecular function
G protein-coupled receptor binding;hormone activity;protein binding